Jazz Pharmaceuticals plc

JAZZRank #173 of 316

Reference Jun 30, 2026 close implied by Form 13F filings

Circulating market cap

$15.64B

Upper bound: lock-ups and restricted stock not reviewed yet.

Traditional market cap: $15.64B
Fully diluted value: $17.14B
Free float market cap: -
Gap to traditional: 0

Circulating supply64.91M / 64.91M

Free float
Locked team
Other restricted

Circulating: 64.91M · 100.0%
Free float: -
Locked team: n/r
Other restricted: n/r
Total outstanding: 64,914,577

Lock-ups and restricted stock for this company have not been reviewed yet. Only unlisted share classes are excluded, so circulating supply is an upper bound.

Supply breakdown

Shares as of Jul 27, 2026

Circulating100.0%64.91M shares

Category	Shares	%	Value	Status
Circulating	64.91M	100.0%	$15.64B	Estimated
Free float	-	-	-	Unavailable
Insider-held, unrestricted	-	-	-	Unavailable
Locked team funds	-	-	-	Unavailable
Other restricted (unlisted classes only)	-	-	-	Unavailable
Total outstanding	64.91M	100.0%	$15.64B	Verified
Ownership views (overlap the categories above, never added)
Institutional holdings (13F)	64.38M	99.2%	$15.51B	Estimated
Insider-held, all (Forms 3, 4, 5)	-	-	-	Unavailable

Institutional and insider holdings can include both tradable and locked shares, so they are shown for reference and never added to the total. Check: no class has more shares deducted than it has outstanding, and the review found no shares that may be counted twice: reconciles.

Valuation

Traditional$15.64B
Fully diluted$17.14B
Circulating$15.64B
Free float-
Locked team value$0
Other restricted value$0

Locked and restricted shares

Not reviewed yet.

Institutional holders

13F, quarter ended Jun 30, 2026

Holder	Shares	% of total
BlackRock, Inc.	5.97M	9.19%
FMR LLC	4.61M	7.10%
VANGUARD PORTFOLIO MANAGEMENT LLC	3.04M	4.68%
VANGUARD CAPITAL MANAGEMENT LLC	2.73M	4.20%
Capital World Investors	2.70M	4.16%
LSV ASSET MANAGEMENT	2.28M	3.50%
FRANKLIN RESOURCES INC	2.04M	3.14%
STATE STREET CORP	2.00M	3.08%
DIMENSIONAL FUND ADVISORS LP	1.71M	2.64%
FULLER & THALER ASSET MANAGEMENT, INC.	1.64M	2.52%

Sum of long share positions in Form 13F reports for the quarter. 13F covers managers with over $100M in US equities; some positions are reported by more than one filer.

Insiders

Forms 3, 4 and 5

Form 4 aggregation pending

Share classes

Class	Listing	Shares outstanding	As of
Ordinary shares	JAZZ on Nasdaq	64,914,577	Jul 27, 2026

Notes and sources

Jazz Pharmaceuticals plc 10-Q for period ended 2026-06-30, Cover page (0001232524-26-000045)
SEC public float (non-affiliates): $6.25B as of Jun 30, 2025, from the 10-K cover. It is a dollar value at a past date, not circulating supply.